SCHEMBL12700253

SCHEMBL12700253

O=C(O)c1ccccc1C(=O)Nc1ccccc1OC(F)F

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.67
▸ HTT P42858 1/20 0.63
▸ SMN1; SMN2 Q16637 1/20 0.63
▸ PLA2G1B P04054 1/20 0.57
▸ ATG4B Q9Y4P1 1/20 0.57
▸ MEN1 O00255 3/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ TAS2R14 Q9NYV8 1/20 0.52
▸ ALDH1A1 P00352 4/20 0.51
▸ MAPT P10636 2/20 0.51
▸ TEAD4 Q15561 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ PYGL P06737 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.48
▸ HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16127861 0.82 CREBBP (0.69) KMT2AHTTSMN1; SMN2PLA2G1BATG4B
SCHEMBL6802094 0.80 KMT2A (1.00) KMT2AHTTSMN1; SMN2MEN1RAB9A
SCHEMBL12172753 0.79 KMT2A (0.67) KMT2ARAB9AALDH1A1TDP1L3MBTL1
SCHEMBL975946 0.79 KDM4E (0.55) KMT2AHTTSMN1; SMN2PLA2G1BATG4B
SCHEMBL5896940 0.79 L3MBTL1 (0.74) KMT2AMEN1RAB9AALDH1A1TDP1
SCHEMBL4585373 0.79 HTT (0.55) KMT2AHTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL18132555 0.77 TAS2R14 (0.67) KMT2AHTTMEN1RAB9ATAS2R14
SCHEMBL2058331 0.77 ALDH1A1 (0.68) KMT2ASMN1; SMN2MEN1RAB9AALDH1A1
SCHEMBL7820773 0.77 KMT2A (0.71) KMT2AHTTSMN1; SMN2MEN1RAB9A
SCHEMBL12700358 0.77 ALDH1A1 (0.66) KMT2ASMN1; SMN2MEN1TAS2R14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10166237-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2019-01-01 — — US disclosed
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2017-04-27 — — US disclosed
US-9464065-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2016-10-11 — — US disclosed
WO-2012129562-A2 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10166237-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, BMP2 KMT2A 3000/4885HTT 3563/4885SMN1; SMN2 3908/4885
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, BMP2 KMT2A 3000/4885HTT 3563/4885SMN1; SMN2 3908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback